Microfluidic Device Cell Segmentation Antibiotic Susceptibility

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current microfluidic devices face challenges in efficiently characterizing cells, particularly in distinguishing target cells from a heterogeneous biological sample and determining the species or serotype of cells, which is crucial for accurate antibiotic susceptibility testing.

Innovation Solution

A microfluidic device with spatially defined and separated cell compartments and immobilized affinity molecules on identification surfaces to capture and identify cells by species, serotype, or group, enabling phenotypic characterization and species identification in a single device.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If phenotypic AST methods are used to directly assess antibiotic effect on bacterial growth, then measurement reliability is improved, but detection time increases to 1-2 days

Engineering Contradiction:
Improvemeasurement reliabilityVSAvoiddetection time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The device segments the bacterial sample into individual cell compartments, allowing parallel observation of multiple cells simultaneously. This segmentation enables rapid statistical analysis of growth responses while maintaining the reliability of direct phenotypic assessment, reducing detection time from days to hours without sacrificing measurement accuracy

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The microfluidic device performs preliminary actions by pre-positioning individual bacterial cells in controlled compartments and establishing observation conditions before antibiotic exposure. This preliminary setup enables immediate monitoring of growth responses once antibiotics are introduced, eliminating the waiting period required in traditional methods while preserving reliable phenotypic measurement

Inventive Principle:
Principle #10Preliminary action

2Loss of time

If genotypic AST methods are used to detect resistance markers, then detection time is reduced, but measurement precision deteriorates due to false negatives from unknown resistance mechanisms

Engineering Contradiction:
Improvedetection timeVSAvoidmeasurement precision
Core Design Contradiction:
Loss of timeVSMeasurement precision

Solution Approach 1:

The system performs self-service by automatically analyzing the actual phenotypic growth responses of individual bacterial cells to multiple antibiotics simultaneously. This self-service approach eliminates the need for pre-specified genetic markers, allowing the system to directly observe and record which antibiotics inhibit which cells, thereby achieving both rapid detection and high precision without false negatives

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The device changes the measurement parameter from genetic marker detection to direct observation of growth rate and cell division under antibiotic exposure. By monitoring dynamic growth parameters such as cell length changes and division events in real-time, the system achieves accurate resistance phenotyping without relying on predetermined genetic markers, thus maintaining both speed and precision

Inventive Principle:
Principle #35Parameter changes

3Productivity

If microfluidic devices are used to miniaturize incubation chambers, then productivity is improved through increased signal to background ratio, but device complexity increases

Engineering Contradiction:
ImproveproductivityVSAvoiddevice complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The microfluidic device segments the sample into numerous individual cell compartments arranged in parallel, enabling simultaneous observation of many cells. This segmentation increases productivity by providing high statistical power and improved signal-to-background ratio through multiplexing, while the modular compartment design keeps the device structure manageable and not excessively complex

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The microfluidic device achieves multi-functionality by integrating cell trapping, antibiotic delivery, time-lapse imaging, and automated analysis capabilities within a single platform. This universality improves productivity by consolidating multiple operations that would otherwise require separate devices, while the integrated design avoids the complexity of coordinating multiple independent systems

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device achieves biologically relevant classification of cells by determining phenotypic responses and identifying species or serotypes, thereby providing a more accurate characterization of cells in complex samples.

Implementation Method 1

at least one identification surface comprising immobilized affinity molecules configured to capture cells of a species or serotype or of a group of species or serotypes

Methodology Applied
Scientific EffectAffinity capture: Adsorption

Data Source

PatentUS12311370B2Microfluidic device for cell characterization
Publication Date: 2025.05.27 ASTREGO DIAGNOSTICS AB
  • US12311370B2 patent drawing
  • US12311370B2 patent drawing
  • US12311370B2 patent drawing

AI summary

A microfluidic device (1) comprises a substrate (10) having spatially defined and separated cell compartments (20) configured to accommodate cells. A respective first end (22) of the spatially defined and separated cell compartments (20) is in fluid connection with a flow input channel (30). The microfluidic device (1) comprises at least one identification surface (60, 61) comprising immobilized affinity molecules configured to capture cells of a species or serotype or of a group of species or serotypes.